Zobrazeno 1 - 10
of 58
pro vyhledávání: '"astragaloside IV (AS-IV)"'
Autor:
Xinhui Zhang, Fan Zhang, Yan Li, Na Fan, Ke Zhao, Anding Zhang, Jiefang Kang, Yan Lin, Xiaochang Xue, Xun Jiang
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Background The specific pathogenesis of UC is still unclear, but it has been clear that defects in intestinal barrier function play an important role in it. There is a temporary lack of specific drugs for clinical treatment. Astragaloside IV
Externí odkaz:
https://doaj.org/article/fcc4ced7e6ef4d20ab3034e2291a4913
Autor:
Huaxian Chen, Xingyang Wan, Qiulan He, Guozhong Xiao, Yihui Zheng, Minyi Luo, Chaoxin Yang, Donglin Ren, Li Lu, Hui Peng, Hongcheng Lin
Publikováno v:
Biomolecules & Biomedicine (2024)
The cellular characteristics of intestinal cells involved in the therapeutic effects of astragaloside IV (AS-IV) for treating slow transit constipation (STC) remain unclear. This study aimed to determine the dynamics of colon tissue cells in the STC
Externí odkaz:
https://doaj.org/article/d19d8d84154f460e847126dc60e2dbb4
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Given the limited treatment options available for kidney disease, a significant number of patients turn to alternative therapies, including traditional Chinese medicine. Among these therapies, the Fufang Shenhua tablet (SHT) has garnered
Externí odkaz:
https://doaj.org/article/219c7190d4d14ada94e480916fc51bd1
Publikováno v:
Alexandria Engineering Journal, Vol 60, Iss 6, Pp 5749-5764 (2021)
From the in vitro level, this paper explores the synergistic inhibitory effects and mechanisms of sodium arsenite (NaAsO2) and astragaloside IV(AS-IV) on HepG2 cells. By screening the optimal concentration of each drug, the authors tested the combine
Externí odkaz:
https://doaj.org/article/6a23d1d194514baaa3f0e0675a69af49
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lianlian Tian, Jun-Long Zhao, Jian-Qin Kang, Shi-bo Guo, Nini Zhang, Lei Shang, Ya-Long Zhang, Jian Zhang, Xun Jiang, Yan Lin
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Inflammatory bowel disease (IBD) is characterized by chronic and relapsing intestinal inflammation, which currently lacks safe and effective medicine. Some previous studies indicated that Astragaloside IV (AS-IV), a natural saponin extracted from the
Externí odkaz:
https://doaj.org/article/4fa59c82609c405397ace16a9939b61f
Publikováno v:
Cellular Physiology and Biochemistry, Vol 49, Iss 6, Pp 2240-2253 (2018)
Background/Aims: Astragaloside IV (AS-IV), a traditional Chinese medicine isolated from Astragalus membranaceus, has been shown to exert cardioprotective effect previously. This study aimed to reveal the effects of AS-IV on hypoxia-injured cardiomyoc
Externí odkaz:
https://doaj.org/article/16d38fcd2c75445bb8caa00ad0e42cc2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Alexandria Engineering Journal, Vol 60, Iss 6, Pp 5749-5764 (2021)
From the in vitro level, this paper explores the synergistic inhibitory effects and mechanisms of sodium arsenite (NaAsO2) and astragaloside IV(AS-IV) on HepG2 cells. By screening the optimal concentration of each drug, the authors tested the combine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f1e46d92fb9e572baba2e58bfcd624
https://doi.org/10.1016/j.aej.2021.03.043
https://doi.org/10.1016/j.aej.2021.03.043